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Abstract
Background: Biofilms have great significance in healthcare-associated infections owing to their inherent tolerance
and resistance to antimicrobial therapies. New approaches to prevent and treat unwanted biofilms are urgently
required. To this end, three seagrass species (Enhalus acoroides, Halophila ovalis and Halodule pinifolia) collected in
Vietnam and in India were investigated for their effects in mediating non-lethal interactions on sessile bacterial
(Escherichia coli) and fungal (Candida albicans) cultures. The present study was focused on anti-biofilm activities of
seagrass extracts, without killing cells.
Methods: Methanolic extracts were characterized, and major compounds were identified by MS/MS analysis. The
antibiofilm properties of the seagrass extracts were tested at sub-lethal concentrations by using microtiter plate
adhesion assay. The performance of the most promising extract was further investigated in elegant bioreactors to
reproduce mature biofilms both at the solid/liquid and the solid/air interfaces. Dispersion and bioluminescent
assays were carried out to decipher the mode of action of the bioactive extract.
Results: It was shown that up to 100 ppm of crude extracts did not adversely affect microbial growth, nor do they
act as a carbon and energy source for the selected microorganisms. Seagrass extracts appear to be more effective
in deterring microbial adhesion on hydrophobic surfaces than on hydrophilic. The results revealed that non-lethal
concentrations of E. acoroides leaf extract: i) reduce bacterial and fungal coverage by 60.9 and 73.9%, respectively; ii)
affect bacterial biofilm maturation and promote dispersion, up to 70%, in fungal biofilm; iii) increase luminescence
in Vibrio harveyi by 25.8%. The characterization of methanolic extracts showed the unique profile of the E. acoroides
leaf extract.
Conclusions: E. acoroides leaf extract proved to be the most promising extract among those tested. Indeed, the
selected non-lethal concentrations of E. acoroides leaf extract were found to exert an antibiofilm effect on C.
albicans and E. coli biofilm in the first phase of biofilm genesis, opening up the possibility of developing preventive
strategies to hinder the adhesion of microbial cells to surfaces. The leaf extract also affected the dispersion and
maturation steps in C. albicans and E. coli respectively, suggesting an important role in cell signaling processes.
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Background
The ability of microorganisms to colonize surfaces and
develop into highly organized communities enclosed in a
self-produced polymeric matrix is the predominant
growth modality in both nature and artificial systems.
Such lifestyle is called biofilm and it is characterized by
alterations in microbial phenotypes with respect to growth
rates and gene transcriptions [1–3].
Biofilms have great significance for public health,
representing 65–80% of microbial diseases currently
treated by physicians in the developed world [4, 5]. The
presence of indwelling medical devices further increases
the risk for biofilm formation and subsequent infection
[6]. The bacterium Escherichia coli and the polymorphic
fungus Candida albicans are among the most frequent
cause of bloodstream infections, and the predominant
microorganisms isolated from infected medical devices
[7, 8]. These biofilms, as any other biofilm, exhibit
dramatically decreased susceptibility to antimicrobial
agents and resistant to the host immune clearance, which
increases the difficulties for the clinical treatment of infec-
tions [9–11]. Furthermore, the antimicrobial arena is ex-
periencing a shortage of lead compounds, and growing
negative consumer perception against synthetic products
has led to the search for more natural solutions [12].
In this context, it has been reported that plant-derived
extracts exhibit good antibiofilm properties against a
range of microorganisms [13–15]. However, in the past,
these extracts were mainly screened by focusing on their
lethal effects [16–18] disregarding their activity at
non-lethal concentrations. At these concentrations,
plant-derived extracts may reveal elegant mechanisms
to sabotage the sessile lifestyle, manipulating the ex-
pression of stage-specific biofilm phenotypes [19]. For
instance, by affecting the cellular ability to attach to
surfaces and by mystifying intercellular signals, the
biofilm cascade might be hampered. Thus, non-lethal
concentrations of plant-derived extracts can inspire in-
novative, eco-friendly and safe strategies aim at treating
deleterious biofilms. Interfering with specific key steps
that orchestrate biofilm genesis might offer new ways
to disarm microorganisms without killing them, side-
stepping drug resistance [4].
Seagrasses, which belong to the halophytes, represent a
functional group of underwater marine flowering plants
that have developed several strategies to survive and re-
produce in environments where the salt concentration is
around 200 mM NaCl or more [20]. As these plants grow
in very high saline conditions, it is predicted that they
could possess rare and new activities not reported for their
terrestrial relatives [21, 22]. Indeed, metabolomic studies
have shown that increased salinity leads to changes in
conserved and divergent metabolic responses in halo-
phytes [23–25]. Moreover, interesting activities of seagrass
extracts, including antibacterial, antifungal, antialgal, anti-
oxidant, anti-inflammatory, insecticidal, antimalarial and
vasoprotective properties, have been reported [26–28].
Thus, the well described properties of seagrasses ex-
tracts offer a promising framework for investigating novel
antibiofilm activities at non-lethal concentrations.
The present study explores, for the first time, the effect
of extracts from different seagrasses (namely, leaves and
roots from Enhalus acoroides Rich. ex Steud., Hydrochari-
taceae, leaves of Halophila ovalis (R.Br.) Hook.f., Hydro-
charitaceae, and leaves of Halodule pinifolia (Miki)
Hartog, Cymodaceaceae) in mediating non-lethal interac-
tions on sessile Candida albicans and Escherichia coli
cultures, selected as model systems for fungal and bacter-
ial biofilm infections, respectively. The work focuses on
investigating the antibiofilm performance of seagrass ex-
tracts at sub-inhibitory concentrations, studying how they
affect biofilm functional traits (such as adhesion, biofilm
maturation, dispersal and quorum sensing), and induce
cellular responses other than those associated with anti-
microbial activities.
Methods
Plant material and extraction
Three species of seagrasses (leaves and roots from
Enhalus acoroides Rich. ex Steud., Hydrocharitaceae,
leaves of Halophila ovalis (R.Br.) Hook.f., Hydrocharita-
ceae, and leaves of Halodule pinifolia (Miki) Hartog,
Cymodaceaceae) were collected in Vietnam and India
and air-dried in a dark place (Table 1). Enhalus acor-
oides and Halophila ovalis were collected and identified
by Xuan-Vy Nguyen, Department of Marine Botany,
Institute of Oceanography, Vietnam Academy of Science
and Technology, Nha Trang City, Vietnam, based on mor-
phological characters and controlled by ITS molecular
marker analysis [29]. Specimens of Enhalus acoroides are
stored in the herbarium of the Institute of Botany,
Hannover, Germany (Specimen number: EA20130301).
Halodule pinifolia was collected by Jutta Papenbrock and
further identified by Thirunavakkarasu Thangaradjou,
Centre of Advanced Study in Marine Biology, Annamalai
University, Parangipettai, Tamilnadu, India, based on mor-
phological characters and controlled by ITS molecular
marker analysis [30]. Specimens are stored in the
herbarium of the Annamalai University, Parangipettai,
Tamilnadu, India.
The plants were separated into different organs (leaves
and roots), and samples were cooled with liquid nitrogen
and ground to a fine powder using a bead mill (Retsch),
three times for 10 s at a frequency of 30/s. The samples
were stored at − 80 °C prior to analysis. Crude extracts
were obtained using 80% methanol (MeOH) as solvent.
Around 50 mg of powdered seagrass material was weighed
in a reaction tube and extracted with 800 μl 80% MeOH
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for 10 min with regular shaking. Then the extract was
centrifuged for 5 min at 18000 x g and the supernatant
transferred into a new reaction tube. These steps were re-
peated three times with 400 μl 80% MeOH each. The su-
pernatants were collected in the same reaction tube and
stored at − 20 °C. Phosphate buffered saline (PBS, 0.01 M
phosphate buffer, 0.0027 M potassium chloride 0.137 M,
sodium chloride, Fisher Scientific) was used to obtain sev-
eral concentrations of each crude extract: 100, 10, 1, 0.1,
0.01 and 0.001 mg/l.
Microbial strains and growth media
The microbial strains Candida albicans SC5314 (ATCC
MYA-2876) and Escherichia coli K-12 wild-type strain
(ATCC 25404) were selected as model systems for fun-
gal and bacterial biofilms respectively. C. albicans and
E. coli strains were stored at − 80 °C in suspensions
containing 50% glycerol and 2% peptone, and were rou-
tinely grown in amino acid-free yeast nitrogen base (YNB,
Sigma-Aldrich) supplemented with 0.5% glucose (YNBG,
Conda) and Luria-Bertani broth (LB, Sigma-Aldrich),
respectively, for 16 h at 30 °C.
Quantification of total flavonoid contents (TFC)
The total flavonoid content of the seagrass extracts was
measured in 96-well plate according to a modified
protocol from Dudonné et al. [31]. The wells were filled
with 150 μl H2O each. Dilutions of the methanolic sea-
grass extracts (1:2) were prepared and 25 μl of sample
were filled in one well, with four replicates. A calibration
curve with catechin hydrate with the following concen-
trations was prepared in 80% MeOH: 0, 10, 25, 50, 100,
125, 250 and 400 μg/ml. The calibration curve was
placed on the plate in triplicate. In the next step, 10 μl
NaNO2 3.75% were added into each well and incubated
for 6 min. Afterwards, 15 μl of AlCl3 10% were added
and incubated for 10 min. In the last step, 50 μl of
NaOH 1 M were added and the absorption was mea-
sured at 510 nm in a microplate reader (Biotek, Winoo-
ski, USA). The slope of the calibration curve was used to
calculate the total flavonoid content in mg catechin
equivalent.
Quantification of total phenolic contents (TPC)
To measure the total phenolic acid content, a modified
protocol after Dewanto et al. [32] was used with the
same extracts described above. 96-well microtiter plate
were filled with 100 μl H2O each. From each sample,
10 μl were added; seagrass extracts were diluted 1:2. A
gallic acid calibration curve with the following concen-
tration was used: 0, 5, 10, 25, 50, 75, 100, 125 and
250 μg/ml. Next, 100 μl Na2CO3 7% were added and the
plate was incubated for 100 min in the dark. The ab-
sorption was measured at 765 nm in a microplate
reader. With the slope of the gallic acid calibration
curve, the concentration of phenolic acids was calculated
in mg gallic acid equivalent.
Determination if the oxygen radical absorbance capacity
(ORAC)
The analysis of the oxygen radical absorbance capacity
(ORAC) was conducted according to a protocol based
on Huang et al. (2002) [33] and Gillespie et al. [34]
with the same extracts. A black 96-well microtiter was
used and the wells were filled with 120 μl fluorescein
(112 nM) in phosphate buffer (75 mM, pH 7.4). Of
each sample and the standard curve, 20 μl were added
in each well. The standard curve of 6-hydroxy-2,
5,7,8-tetramethylchroman-2-carboxylic acid (Trolox)
was prepared in phosphate buffer with the following
concentrations: 6.25, 12.5, 25 and 50 μM. Seagrass
extracts were diluted 1:200 with methanol 80%. The
microtiter plate was incubated for 15 min at 37 °C. The
fluorescence was then measured at 485/520 nm as time
point zero. Next, 80 μl of 2,2′-azobis(2-amidino-propane)
dihydrochloride (62 mM) were added and the fluores-
cence was measured every minute for 80 min. The ORAC
value was calculated as the difference between time point
zero and 80 min and quantified with the Trolox standard
curve.
LC-MS analysis
LC-MS analysis was performed on a Shimadzu HPLC
system (controller CBM-20A, two pumps LC-20 AD, a
column oven CTO-20 AC and a photo diode array
detector SPD-M20A; Shimadzu, Darmstadt, Germany)
Table 1 Seagrass species and information about collection sites
Species Plant organ Collection site GPS Collection date
Enhalus acoroides Leaf Nha Trang Bay, Vietnam 109.209208°E
12.158073°N
19.04.2011
Enhalus acoroides Root Nha Trang Bay, Vietnam 109.209208°E
12.158073°N
19.04.2011
Halophila ovalis Leaf Nha Trang Bay, Vietnam 109.209208°E
12.158073°N
19.04.2011
Halodule pinifolia Leaf Chilika Lagoon, India 85.418015°E
19.775105°N
16.02.2010
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coupled to a Triple Tof 4600 mass spectrometer (AB
Sciex, Canby, USA). The separation of extracted com-
pounds was realised on a Knauer Vertex Plus column
(250 × 4 mm, 5 μm particle size, packing material
ProntoSIL 120–5 C18-H) with precolumn (Knauer,
Berlin, Germany). The column oven temperature was
set to 30 °C and 25 μl of undiluted methanolic seagrass
extract prepared as described above was injected. The
solvent flow rate was 0.8 ml/min. In this time, a gradi-
ent was run from 10 to 90% B from minute 0 to 35,
2 min of 90% B, switch to 10% B in 1 min and subse-
quent equilibration at 10% B for 2 min. Solvent A
(water) and B (methanol) were both supplemented with
2 mM ammonium acetate and 0.01% acetic acid. Mass
spectra were monitored between 100 and 800 Da in
negative ionisation mode. In addition, MS/MS spectra
were generated with a collision energy of − 30 eV and
measured between 50 and 800 Da. Spectra for the most
prominent peaks were compared to database entries in
MassBank [35] and ReSpect [36] for identification.
Planktonic growth in the presence of seagrass extracts as
the sole source of carbon and energy
The ability of C. albicans and E. coli planktonic cells to
grow in the presence of each extract as the sole carbon
and energy source was tested using YNB and M9
(Sigma-Aldrich) mineral medium, respectively, supple-
mented with the highest working extract concentration:
100 mg/l. Then a 100 μl mix of mineral medium to-
gether with 45 μl (3% v/v) of the overnight culture (final
concentration 108 cells/ml) and the highest concentra-
tion of each marine plant extract were used to fill each
well of 96-well plates (Thermo Fisher Scientific) and in-
cubated for 48 h at 30 °C. A medium complemented
with cells and glucose (5 g/l), and medium without cells,
were used as positive and negative controls, respectively.
Microbial growth was monitored using the PowerWave
XS2 microplate reader (Biotek) measuring the absorb-
ance at 600 nm (A600) every 10 min. Six biological repli-
cates of each treatment were performed. The obtained
data were normalized to the negative control and re-
ported as the mean of these.
Growth inhibition assay in the presence of seagrass
extracts
The ability of the seagrass extracts to inhibit the plank-
tonic growth of the selected microorganisms was investi-
gated. For this, C. albicans and E. coli were grown YNBG
and LB broth respectively without (positive control) and
with the highest working concentrations (10 and 100 mg/
l) in 96-well plates (Thermo Fisher Scientific). Growth
curves at 30 °C were generated using Infinite® F200 PRO
microplate reader (TECAN, Mannedorf, Switzerland) by
measuring the optical density at 600 nm (OD600) every
60 min for 30 h in wells inoculated with 45 μl (3% vol/vol)
of an overnight culture (approximately 108 cells/ml). The
negative control was represented by PBS supplemented
with 45 μl (3% vol/vol) of the overnight culture. The
polynomial Gompertz model [37] was used to fit the
growth curves to calculate the maximum specific growth
rate (A600/min), using GraphPad Prism software (version
5.0, San Diego, CA, USA). Five biological replicates of
each treatment were performed.
Microplate-based biofilm assay
The antibiofilm activity of seagrass extracts was assessed
quantitatively as previously reported by Villa et al. [38].
Briefly, 200 μl of PBS containing 108 cells/ml supple-
mented with 0 (positive control), 100, 10, 1, 0.1, 0.01,
and 0.001 mg/l of each crude extract were placed in
hydrophobic and hydrophilic 96-well polystyrene-based
microtiter plates (Thermo Fisher Scientific). After an
incubation time of 24 h at 20 °C, C. albicans and E. coli
planktonic cells were removed and adhered cells were
stained using 0.1 mg/ml of Fluorescent Brightener 28 vital
dye (Sigma-Aldrich) or 4′, 6-diamidino-2-phenylindole
(DAPI, Sigma-Aldrich) in PBS, respectively. After 20 min
staining in the dark at room temperature the microtiter
plates were washed twice with 200 μl PBS and the fluores-
cence intensity due to adhered cells was measured using a
fluorescence microplate reader (TECAN, Manneford,
Switzerland) at excitation wavelength of 335 nm and emis-
sion wavelength of 433 nm. A standard curve of fluores-
cence intensity versus cell number was determined and
used to quantify the antibiofilm performance of the crude
extracts. Percentage reduction with respect to the positive
control is calculated as (treated data –control data) × 100
/ control data. Cattò et al. [39] proposed the following
anti-adhesion ranges computing the percentage reduction
in comparison to the negative control: ≤20% without
anti-adhesion activity; between 20 and 30% and 30 and
40% low anti-adhesion activity and with moderate
anti-adhesion activity respectively; ≥40% adhered cells
with excellent anti-adhesion activity. Five biological repli-
cates were performed for each condition and a percentage
reduction in comparison to the negative control was
calculated as (treated data – positive control data) × 100/
positive control data. The experiment was repeated three
times.
Biofilm growth at the solid/liquid interface
The most promising plant extracts were screened for
their effects on biofilm development. C. albicans biofilm
was grown in the CDC biofilm reactor (Biosurface
Technologies, Bozeman, MT, USA) as previously de-
scribed by Villa et al. [40]. Briefly, two bioreactors hosting
24 polycarbonate coupons (to simulate a hydrophobic
surface) were filled with YNBG and 1 ml of overnight
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planktonic culture (approximately 108 cells/ml) and, in
one of them, 0.01 mg/l of E. acoroides leaf extract was
added. Bioreactors were maintained under static condi-
tions (no flow) for 24 h under mild stirring at 37 °C, pro-
moting fungal adhesion to the surface of the removable
polycarbonate coupons. After that, the dynamic phase was
initiated and diluted YNGB was fluxed for 48 h at flow
rate of 250 ml/h. Biofilm growth in the absence (positive
control) and presence of the extract was evaluated by
quantification of the biomass. At different time steps (24,
48 and 72 h) some polycarbonate coupons were collected
in aseptic conditions and resuspended in 3 ml of PBS
each. Subsequently, serial dilutions were carried out, and
10 μl were inoculated in petri dishes containing Tryptic
Soy Broth medium (TSB, Sigma-Aldrich) complemented
with agar (Merck) following the drop counting method.
After 12 h at 30 °C, C. albicans colonies were counted and
the data obtained were normalized to the coupon area,
and means were reported. The same protocol was used to
obtain mature biofilm of E. coli, using LB as a medium,
and evaluating 10 mg/l of E. acoroides leaf extract. Each
experiment was repeated three times.
Biofilm dispersion assay
Mature C. albicans biofilm was grown in the CDC
reactor in the absence (positive control) and presence
and of 0.01 mg/l of E. acoroides leaf extract as reported
below. As previously described by Cattò et al. [41], after
72 h polycarbonate coupons were collected, immersed in
27 ml of PBS for one minute at room temperature, serial
dilutions were carried out and 10 μl were inoculated in
petri dishes containing TSB supplemented with agar
(Merck) following the drop counting method. After 12 h
at 30 °C, C. albicans colonies were counted and the per-
centage of biofilm dispersion was calculated as (number
of viable cells from bulk PBS × 100) / (number of viable
cells from bulk PBS + number of viable cells from the
coupon biofilm) and means were reported. Three bio-
logical replicates were performed for each treatment and
six technical replicates were performed for each experi-
ment. The experiment was performed three times.
Biofilm growth at the solid/air interface
E. coli biofilm was grown on a sterile polycarbonate mem-
brane (PC, Whatman Nucleopore, diameter 2.5 cm, pore
diameter 0.2 μm) as previously described by Garuglieri et
al. [42]. Briefly, 0.05 ml of an overnight culture (approxi-
mately 106 cells/ml) were inoculated at the center of a
sterile polycarbonate membrane and, when the inoculum
was completely dried, the membrane was carefully put in-
side a transwell structure (ThinCert™ Cell Culture Inserts
with translucent PET membrane – Greiner bio-one) inlaid
in a 6 well culture plate (Greiner bio-one). One ml of LB
medium was inoculated in the basolateral compartment
(plate well). Biofilm formation was performed at 37 °C in
aerobic conditions for 16 h. At different time points (0, 4,
6, 8, 16 h) some membranes were removed, biofilm was
scraped off using a sterile loop, put inside a tube contain-
ing 1 ml of PBS and then homogenized twice using a
homogenizer (IKA T10 basic Ultra-Turrax – Cole-Parmer
Instrument Company). Then serial dilutions were pre-
pared and 10 μl were inoculated in petri dishes containing
LB with agar following the drop counting method. After
12 h at 37 °C, E. coli colonies were counted and the bio-
mass was quantified. This assay was assessed under three
experimental conditions: i) treatment 1: growth in contact
with 1 ml of LB with 10 mg/l of E. acoroides leaf extract
for 16 h; ii) treatment 2: overnight culture grown with
10 mg/l of E. acoroides leaf extract, and then growth in
contact with 1 ml of LB for 16 h; iii) treatment 3: over-
night culture grown with 10 mg/l of E. acoroides leaf ex-
tract, and then growth in contact with 1 ml of LB with
10 mg/l of E. acoroides leaf extract for 16 h. In the positive
control, the microorganisms grew in 1 ml LB inside a
basolateral well for 16 h without the extract. The data ob-
tained were divided by the area of the membrane, and the
means were reported. The experiment was repeated three
times.
B2ioluminescence assay using Vibrio harveyi
Two hundred μl of autoinducer bioassay (AB) mineral
medium (0.3 M NaCl, 0.05 M MgSO4, 0.5% casein
hydrolysate, 10 μM KH2PO4, 1 μM L-arginine, 50%
glycerol, 0.01 μg/ml riboflavin, 1 μg/ml thiamine. pH 7.
Sigma-Aldrich) containing 10% (V/V) of a tenfold dilu-
tion of an overnight culture of Vibrio harveyi BB170
(ATCC BAA-1117) grown in AB medium were supple-
mented with 10 mg/l of E. acoroides leaf extract re-
spectively, and were placed in hydrophobic 96-well
polystyrene-based microtiter plates (Thermo Fisher
Scientific) with transparent bottom. The positive control
was an AB mineral medium supplemented with 10% (V/
V) tenfold dilution of the overnight culture. Absorbance
(OD600nm) and luminescence were measured using a mi-
croplate reader (VICTOR™X, Perkin Elmer, USA) every
8 h for 24 h, incubating the microtiter plate at 30 °C
during the experiment. The data obtained were normal-
ized to the number of viable cells, divided by the area of
the membrane, and the means reported. The experiment
was repeated three times.
Statistical analysis
To evaluate statistically significant differences among
samples, analysis of variance (ANOVA) via MATLAB
software (Version 7.0, The MathWorks Inc., Natick,
USA) was applied. Tukey’s honestly significant different
test (HSD) was applied for pairwise comparison to
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establish the significance of the data. Statistically sig-
nificant results were represented by P values ≤0.05.
Results
Seagrass extracts contain phenolic compounds and show
antioxidant capacities
The methanolic extracts from the seagrass material
contained phenolic acids as well as flavonoids (Fig. 1a-b).
The content of phenols and flavonoids was highest in H.
pinifolia leaf extracts with 18.0 ± 0.25 and 14.3 ± 0.25 mg/
g dry mass (DM), respectively. In E. acoroides, the root
material showed higher amounts of total flavonoids and
phenols than the leaf material. For all seagrass species, the
content of phenolic acids was higher than the flavonoid
content with respect to the DM.
Methanolic extracts from the four seagrass species
were analyzed for their antioxidant capacity (Fig. 1c).
All tested extracts had the ability to absorb oxygen rad-
icals. H. pinifolia showed the highest activity with 97.7
± 2.7 mg Trolox equivalents (TE)/g DM. E. acoroides
and H. ovalis leaf extracts showed similar antioxidant
capacities with 70.2 ± 4.1 and 72.5 ± 2.9 mg TE/g DM,
respectively. The root extract from E. acoroides displayed
a lower ORAC value than the extract from the leaves
(45.1 ± 3.2 mg TE/g DM).
LC-MS analysis of secondary metabolites
E. acoroides, H. ovalis and H. pinifolia show different
compositions of secondary metabolites (Fig. 2). The
identification of individual compounds in the methanolic
extracts was done via the comparison of MS/MS spectra
with database entries. The three seagrass species showed
different profiles of secondary metabolites, in this case
mainly flavonoids and phenolic acids (Table 2). In E. acor-
oides leaves, three flavonoles based on kaempferol were
found. In addition, two flavones (apigenin and luteolin),
one phenolic acid (benzoic acid) and the saturated dicar-
boxylic acid azelaic acid were identified. The root extract
of E. acoroides also contained two kaempferol-based flavo-
noles and luteolin and also a procyanidin and a flavanole
(epicatechin). In H. ovalis three flavonoids and one phen-
olic acid was found. H. pinifolia contained several flavo-
noles, either based on kaempferol or quercetin and also
epicatechin.
Seagrass extracts are not used as carbon and energy
source by C. albicans and E. coli and do not affect their
planktonic growth
C. albicans and E. coli planktonic cells grown only in the
presence of medium supplemented with glucose were
used as the positive control of the experiment (Fig. 3).
Note that the mineral medium supplemented with the
highest concentration of tested plant extracts did not
promote the growth of the selected microorganisms.
The response of the planktonic growth of the selected
microorganisms in the presence of the seagrass extracts at
the highest concentrations (10 and 100 mg/l) is reported
in Figs. 4 and 5. C. albicans and E. coli growth rates (table
in Figs. 4 and 5) showed that there are no statistically sig-
nificant differences between the presence and the absence
of the extracts obtained from every plant portion at any
tested concentration. Therefore, concentrations ≤100 mg/l
plant extract were used in the subsequent studies.
E. acoroides leaf extract inhibits cell adhesion on a
hydrophobic surface
The percentage reduction of the number of adhered cells
of E. coli and C. albicans on hydrophilic and hydrophobic
surface in presence of non-lethal concentrations of sea-
grass extracts is showed in Fig. 6. The results revealed that
E. acoroides and H. ovalis were the most promising ex-
tracts for C. albicans, with excellent anti-adhesion activity,
reducing fungal coverage up to 73.89 ± 1.01% and 68.37 ±
2.49% at 0.01 and 1 mg/l, respectively. For E. coli, 10 mg/l
of E. acoroides leaf extract was found to be the concentra-
tion with the highest reduction in cell adhesion (reduction
Fig. 1 Crude methanolic extracts were analyzed for (a) Total phenols in mg gallic acid equivalent (GAE) per g dry mass (DM), (b) Total flavonoids
in mg catechin equivalent (CE) per g DM, and (c) ORAC in mg Trolox equivalents (TE) per g DM. Data represent the mean ± SDs and different
superscript letters indicate statistically significant differences (Tukey’s HSD, p≤ 0.05) between the means of three independent measurements.
(EAL = Enhalus acoroides leaf; EAR = Enhalus acoroides root; HPL = Halodule pinifolia leaf; HOL = Halophila ovalis leaf)
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of bacterial coverage by 60.86 ± 8.85%). Therefore, 0.01 mg/
l and 10 mg/l E. acoroides leaf extract were chosen as the
best non-biocidal concentrations for C. albicans and E. coli
respectively, and were used in the subsequent studies.
E. acoroides leaf extract does not impact on biofilm
growth curves, but does induce biofilm dispersion in C.
albicans and interfere with AI2
A CDC reactor was used as the laboratory scale model
system to grow a complex and mature C. albicans biofilm
in the absence and presence of 0.01 mg/l E. acoroides leaf
extract, the most effective concentration obtained from
the adhesion assay.
Results in Fig. 7a indicated a significant reduction in the
number of viable cells adhered on coupon surfaces treated
with the extract, compared to the untreated ones, after
24 h (reduction of fungal coverage up to 26.77 ± 9.01%).
Coupons collected after 48 and 72 h showed no significant
differences between the treated biofilm and the control.
A significant increase in the number of dispersed
cells in the treated biofilm (70 ± 6.83%) was observed
(Fig. 7b).
A colony biofilm assay was used to grow a complex
and mature E. coli biofilm in the presence and absence
of 10 mg/l E. acoroides. Results in Fig. 8 showed no sig-
nificant reduction in the number of viable cells during
biofilm formation on the membrane treated with the
extract, compared to the untreated, after 18 h in all the
experimental conditions. Treatment 3 showed a growth
rate slowdown in the interval 6–8, in which E. coli cells
were in contact with the extract during both overnight
growth and biofilm formation (reduction of cellular
growth, compared to the control, up to 48.64 ± 4.02%).
This growth curve was characterized by two exponen-
tial phases separated distinctly by an intermediate
phase where the growth rate is very low. After that, at
16 h the number of viable cells was similar to the other
treatments.
The effects of 10 mg/l of E. acoroides leaf extract on
the cellular communication of V. harveyi were reported
in Fig. 9. The results highlighted a significant increase in
the relative luminescence emitted at time 8 h compared
to the control (25.75 ± 7.49%).
Discussion
Biofilm resistance to antimicrobial agents is a major
worldwide health care issue. Therefore, a successful re-
duction of surface colonization can be a potential strat-
egy for the management of unwanted biofilms, especially
on medical devices and work surfaces.
In this context, the use of plant-derived extracts to
modulate biofilm genesis and dispersion may be a viable
alternative. The present study is the first report describ-
ing the antibiofilm efficacy of non-lethal concentrations
of E. acoroides, H. pinifolia and H. ovalis methanol
extracts in counteracting microbial biofilms, highlighting
the possibility that the selected seagrass species act as an
extracellular signal mediating their biofilm activities.
E. coli and C. albicans were chosen as model systems
for bacterial and fungal infections, respectively. E. coli
Fig. 2 Chromatograms from E. acoroides leaf extract (a), E. acoroides root extract (b), H. ovalis leaf extract (c) and H. pinifolia leaf extract (d) from
minute 0–33. The relative intensity of mass between 100 and 800 Da is shown. Numbers indicate putatively identified substances in Table 2
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Table 2 Individual compounds identified by comparison of MS/MS spectra with database entries in Enhalus acoroides leaf extract
(A), E. acoroides root extract (B), Halophila ovalis leaf extract (C) and Halodule pinifolia leaf extract (D)
No RT Mass MS/MS Name Accession Source
A - E. acoroides leaf extract
1 2.5 343.03 201.02, 157.03, 59.01 n. i. – –
2 2.7 312.12 179.05, 132.06, 89.02 n. i. – –
3 3.3 367.1 277.07, 187.04, 157.03 n. i. – –
4 7.2 134.04 107.03, 92.02 Adenine PT200393 ReSpect
5 13.7 637.1 461.07, 285.04 Kaempferol-3-glucuronide, mod. PT209240 ReSpect
6 14.8 275.15 233.12, 119.05 n. i. – –
7 15.2 121.03 92.02, 77.03 Benzoic acid KO000321 MassBank
8 18.6 527.02 285.04, 241.00, 96.96 n. i. – –
9 20.1 511.05 269.04, 241.00, 96.96 n. i. – –
10 20.8 187.09 169.08, 125.09, 97.06 Azelaic acid KO000124 MassBank
11 21.3 447.09 285.04 Kaempferol-3-O-glucoside PS042209 ReSpect
12 22.5 461.07 285.04 Kaempferol-3-glucuronide PS092408 ReSpect
13 27.5 285.04 151.00, 133.03 Luteolin PS040410 ReSpect
14 29.5 269.04 225.05, 151.00, 117.03 Apigenin PT203930 ReSpect
B - E. acoroides root extract
1 2.4 343.03 201.02, 157.03, 59.01 n. i. – –
2 2.7 312.12 179.05, 132.06, 89.02 n. i. – –
3 2.9 377.08 341.11, 179.05, 119.03, 89.02 Galactinol dihydrate, mod. PT211910 ReSpect
4 4.3 216.98 173.02, 156.98, 136.94, 59.01 n. i. – –
5 7.2 134.04 107.03, 92.02 Adenine PT200393 ReSpect
6 9.6 577.12 451.10, 425.08, 407.07, 289.07, 125.02 Procyanidin B2 PT204580 ReSpect
7 12.3 289.07 245.07, 203.07, 151.04, 109.03 +(−) Epicatechin PT204560 ReSpect
8 13.8 637.1 461.07, 285.04 Kaempferol-3-glucuronide, mod. PT209240 ReSpect
9 14.0 469.08 275.02, 193.05, 178.02, 149.06, 96.96 n. i. – –
10 14.8 275.15 233.12, 119.05 n. i. – –
11 15.3 121.03 92.02, 77.03 Benzoic acid KO000321 MassBank
12 20.8 187.09 169.08, 125.09, 97.06 Azelaic acid KO000124 MassBank
13 22.6 461.07 285.04 Kaempferol-3-glucuronide PS092408 ReSpect
14 24.1 299.05 284.03, 256.03, 133.03 Kaempferide PT204030 ReSpect
15 27.5 285.04 151.00, 133.03 Luteolin PS040410 ReSpect
16 29.5 269.04 225.05, 151.00, 117.03 Apigenin PT203930 ReSpect
17 31.2 329.23 229.14, 211.13, 171.10 n. i. – –
C - H. ovalis leaf extract
1 2.4 343.03 201.02, 157.03, 59.01 n. i. – –
2 2.9 377.08 341.11, 179.05, 119.03, 89.02 Galactinol dihydrate, mod. PT211910 ReSpect
3 4.3 216.98 173.02, 156.98, 136.94, 59.01 n. i. – –
4 13.3 261.04 217.05, 189.05, 133.02 n. i. – –
5 15.5 121.03 92.02, 77.03 Benzoic acid KO000321 MassBank
6 16.3 306.17 288.16 n. i. – –
7 17.5 479.08 316,02 Myricetin-3-galactoside PS092809 ReSpect
8 19.5 463.09 301,03 Quercetin-3-O-beta-D-galactoside PS046509 ReSpect
9 20.8 187.09 169.08, 125.09, 97.06 Azelaic acid KO000124 MassBank
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biofilms are found to be the major causative agent of
many intestinal infections, for recurrent urinary tract in-
fections, and it also responsible for indwelling medical
device-related infectivity [43]. C. albicans is one of the
very few fungal species causing disease in humans. These
infections range from superficial mucosal and dermal
infections, such as thrush, vaginal yeast infections, and
diaper rash, to vascular catheters and dental implants
infections [44].
The bioactive properties of the seagrass species selected
in this work are well known, and have been reported in
detail by several authors [45–47]. However, until now
attention has mainly focused on the antimicrobial activity
of seagrass extracts, which, through disk diffusion assays,
were investigated not in their capacity as biofilm-forming
microorganisms but in their planktonic state. Using lethal
concentrations, Umamaheshwari et al. [46] reported the
antibacterial activity of H. ovalis and H. pinifolia extracts,
obtained using different solvents, against different micro-
bial strains, recording maximum antibacterial activity by
the ethanol extract of H. pinifolia. Instead, Choi et al. [48]
reported the antimicrobial properties of Zostera marina
methanol extract and its organic solvent fractions on three
human skin pathogens (Staphylococcus aureus, S. epider-
midis and C. albicans), and Natrah et al. [47] reported the
antibacterial properties of methanol extracts of E. acor-
oides and other seagrass and seaweed species on different
aquaculture pathogens (Aeromonas hydrophila, Vibrio
alginolyticus, V. parahaemolyticus, V. anguillarum and
others).
In contrast, to the best of our knowledge, no papers
have investigated the antibiofilm activity of Enhalus
acoroides, Halodule pinifolia and Halophila ovalis at
non-lethal concentrations against bacterial (E. coli) and
Table 2 Individual compounds identified by comparison of MS/MS spectra with database entries in Enhalus acoroides leaf extract
(A), E. acoroides root extract (B), Halophila ovalis leaf extract (C) and Halodule pinifolia leaf extract (D) (Continued)
No RT Mass MS/MS Name Accession Source
10 21.1 317.02 271.02, 149.02 n.i. – –
11 21.3 447.09 285.04 Kaempferol-3-O-glucoside PS042209 ReSpect
12 23.5 301.03 255.03, 165.02, 133.03 n.i. – –
13 24.1 299.05 284.03, 256.03, 133.03 Kaempferide PS040309 ReSpect
14 25.7 285.04 239.03, 185.06, 143.05, 117.03 Kaempferol PR040027 MassBank
15 27.5 285.04 285.04, 151.00,133.02 Luteolin PT204043 ReSpect
16 29.4 269.04 225.05, 151.00, 117.03 Apigenin PT203930 ReSpect
D - H. pinifolia leaf extract
1 2.4 343.03 201.02, 157.03, 59.01 n. i. – –
2 2.9 377.08 341.11, 179.05, 119.03, 89.02 Galactinol dihydrate, mod. PT211910 ReSpect
3 4.3 216.98 173.02, 156.98, 136.94, 93.03, 59.01 n. i. – –
4 6.6 473.07 311.04, 293.03, 179.03, 149.01 n. i. – –
5 9.6 577.12 451.10, 425.08, 407.07, 289.07, 125.02 Procyanidin B2 PT204580 ReSpect
6 12.1 289.07 245.07, 203.07, 151.04, 109.03 +(−) Epicatechin PT204560 ReSpect
7 14.0 469.08 275.02, 193.05, 178.02, 149.06, 96.96 n. i. – –
8 19.1 641.17 473.13, 311.07, 167.03 n. i. – –
9 19.7 549.09 505.10, 463.09, 300.02, 271.02, 255.02 Quercetin-3-(6-malonyl)-glucoside PT209340 ReSpect
10 20.8 187.09 169.08, 125.09, 97.06 Azelaic acid KO000124 MassBank
11 21.1 505.09 463.08, 300.02, 271.02 Quercetin-3-O-beta-D-galactoside, mod. PT204650 ReSpect
12 21.8 463.08 300.03, 271.02 Quercetin-3-O-beta-D-galactoside PT204650 ReSpect
13 22.4 433.07 300.02, 271.02, 255.03, 179.00 Quercetin-3-arabinoside PT209320 ReSpect
14 23.4 447.09 284.03, 255.03, 227.03 Kaempferol-3-glucoside PT209270 ReSpect
15 24.6 417.08 284.03, 255.03, 227.03 Kaempferol-3-O-alpha-L-arabinoside PT209220 ReSpect
16 26.3 301.03 178.99, 151.00, 121.03, 107.01 Quercetin PT204090 ReSpect
17 27.4 285.04 199.03, 175.04, 151.00, 133.02 Luteolin PT204043 ReSpect
18 27.7 315.05 300.02, 271.02, 255.03 Isorhamnetin PM007432 ReSpect
19 29.5 269.04 225.05, 151.00, 117.03 Apigenin PT203930 ReSpect
No = number of peak in Fig. 9, RT = retention time, Mass =mass of precursor ion, MS/MS = fragment spectra obtained at − 30 eV, Accession = accession number in
database, Source = database used, n. i. = not identified, mod. = modified
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Fig. 3 E. coli (a) and C. albicans (b) planktonic growth without (positive control) and with each seagrass extract at 100 ppm. The positive control
was set up with mineral medium supplemented with glucose at 5 g/l. Stars indicate statistically significant differences (Tukey’s HSD, p≤ 0.05)
between the means of three independent replicates. (EAL = Enhalus acoroides leaf; EAR = Enhalus acoroides root; HPL = Halodule pinifolia leaf; HOL
= Halophila ovalis leaf; C + = Positive control)
Fig. 4 OD-based growth curves of C. albicans in absence (positive control) and in presence of each seagrass extract at 10 and 100 ppm.
Maximum specific growth rate (μm) and the goodness of fit (R2) obtained by the Gompertz model. Data represent the mean ± SDs of three
independent measurements. Means reported showed no statistically significant differences between the positive control and treated
samples (Tukey’s HSD, p ≥ 0.05). (EAL = Enhalus acoroides leaf; EAR = Enhalus acoroides root; HPL = Halodule pinifolia leaf; HOL = Halophila
ovalis leaf; C + = Positive control)
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fungal (C. albicans) biofilms. To this end, methanol ex-
tracts, obtained from different organs of three seagrass
species (namely, Enhalus acoroides leaves and roots,
Halophila ovalis leaves and Halodule pinifolia leaves)
were screened for their ability to modulate biofilm gen-
esis without killing cells. Methanol was used as the
extraction solvent, having been previously reported as
the most effective solvent to obtain high concentra-
tions of bioactive compounds with antibacterial activity
from seagrasses, compared to other extraction solvents
[45, 49, 50].
Before evaluating the antibiofilm activity, the extracts,
at concentrations of 100 mg/l, were first proved to not
act as a carbon and energy source nor to affect the
cellular growth of C. albicans and E. coli. Therefore,
concentrations ≤100 mg/l plant extract were used in
the subsequent studies.
With the aim of investigating the effects of seagrass
extracts on cell adhesion to surfaces, the first step of
biofilm formation, microtiter based assays were per-
formed. The results revealed excellent anti-adhesion ac-
tivity for E. acoroides leaf extract, reducing fungal
coverage up to 74% and bacterial coverage up to 61% at
0.01 and 10 mg/l, respectively. Therefore, 0.01 mg/l and
10 mg/l E. acoroides leaf extract were chosen as the
best non-biocidal concentrations for C. albicans and E.
coli respectively, and were used in the subsequent stud-
ies. These concentrations significantly decreased the
number of adhered cells on a hydrophobic surface,
more so than on the hydrophilic one. Previous studies
had highlighted the preference for hydrophobic sur-
faces, these reporting a decreased adhesion on the
hydrophobic surface compared to the hydrophilic [51,
52]. This is probably due to the hydrophobic nature of
the aerial surfaces of plants [53].
In the present study the anti-adhesion activity of the
seagrass extracts was dose-dependent, but the highest
concentrations did not correspond to those with the
Fig. 5 OD-based growth curves of E. coli in absence (positive control) and in presence of each seagrass extract at 10 and 100 ppm.
Maximum specific growth rate (μm) and the goodness of fit (R2) obtained by the Gompertz model. Data represent the mean ± SDs of
three independent measurements. Means reported showed no statistically significant differences between the positive control and treated
samples (Tukey’s HSD, p ≥ 0.05). (EAL = Enhalus acoroides leaf; EAR = Enhalus acoroides root; HPL = Halodule pinifolia leaf; HOL = Halophila
ovalis leaf; C + = Positive control)
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best performance. Indeed, several studies have reported
a weak activity of the compounds at low and high
concentrations, and excellent activity at intermediate
concentrations [54]. Such a response, widely known in
literature, is defined as hormesis, an adaptive behavior
of microorganisms to provide resistance to environ-
mental stress and improve the allocation of resources
to ensure cell stability [19, 55].
Fig. 6 Microplate-based biofilm assay. Percentage reduction of the number of adhered cells of E. coli and C. albicans on hydrophilic and
hydrophobic surface in presence of non-lethal concentrations of seagrass extracts. According to post hoc analysis (Tukey’s HSD, p≤ 0.05), stars
indicate statistically significant differences between the means of three independent replicates. In addition, the mean ± SDs of the percentage
reduction of the number of adhered cells with seagrass extracts at non-lethal concentrations on hydrophilic and hydrophobic surface are
reported in the table. The higher anti-adhesion effect for each microorganism was highlighted. (EAL = Enhalus acoroides leaf; EAR = Enhalus
acoroides root; HPL = Halodule pinifolia leaf; HOL = Halophila ovalis leaf)
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To further explore the effect of the most promising
seagrass extract on biofilm development and detachment,
CDC reactors were employed to reproduce biofilm at the
solid/liquid interface, while for the assessment of the anti-
biofilm effect in the adhesion phase microplate-based
biofilm assays are the most suitable [41, 56, 57]. In this
study, a significant reduction in fungal coverage (up to
26.77 ± 9.01%) after 24 h (static adhesion phase) was
observed in presence of 0.01 mg/l E. acoroides leaf
extract. This result confirms the anti-adhesion activity
observed in microtiter assays. Coupons collected after
48 and 72 h showed no significant differences between
treated and control samples.
In order to assess the possibility of 0.01 mg/l E. acoroides
leaf extract to promote C. albicans biofilm-detachment
from the surface of coupons, a biofilm dispersion assay
was performed. Results showed a significant increase in
the number of dispersed cells in the treated biofilm,
compared with the untreated (70 ± 6.83%), suggesting
a further mechanism of action for the seagrass extract
as biofilm dispersing agent. In fact, the phase of bio-
film dispersion could be an interesting target for the
development of new antibiofilm strategies, forcing the
planktonic state and reestablishing the efficacy of
traditional antimicrobial agents [4, 58]. Literature with
information related to C. albicans biofilm dispersion is
scarce. Farnesol and cis-2-decenoic acid showed
dispersion-promotion of microcolonies of C. albicans
biofilm [58, 59]. In addition, Villa et al. [60] reported that
non-lethal concentrations of Muscari comosum ethanol
bulb extract can modulate yeast adhesion and subsequent
biofilm development on abiotic surfaces, and such con-
centrations could provide an extracellular signal respon-
sible for biofilm dispersion.
Fig. 7 CDC biofilm growth on polycarbonate coupons (a) and biofilm dispersion rate (b) of C. albicans in absence (positive control) and in
presence (treated) of 0.01 ppm of Enhalus acoroides leaf extract. Stars indicate statistically significant differences (Tukey’s HSD, p ≤ 0.05) between
the means of three independent replicates. (C + = Positive control; EAL = Enhalus acoroides leaf)
Fig. 8 Biofilm growth at the solid/air interface. E. coli biofilm grown on polycarbonate membrane under three experimental conditions: i)
treatment 1: growth in contact with 1 ml of LB with 10 ppm of E. acoroides leaf extract; ii) treatment 2: overnight culture grown with 10 ppm of
E. acoroides leaf extract and then growth in contact with 1 ml of LB; iii) treatment 3: overnight culture grown with 10 ppm of E. acoroides leaf
extract and growth in contact with 1 ml of LB with 10 ppm of E. acoroides leaf extract. In the positive control, microorganisms grew in 1 ml LB
inside a basolateral well without the extract. Data obtained were divided by the area of the membrane, and means were reported. The experiment
was repeated three times. (T1 = treatment 1; T2 = treatment 2; T3 = treatment 3; C + = Positive control)
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For E. coli, the CDC reactor was not suitable to evalu-
ate the possible effects of the extracts on the biofilm
stages. Also other authors have reported the poor biofilm
formation exhibited by E. coli K-12 strain under hydro-
dynamic conditions [61–63]. The effect of 10 mg/l of E.
acoroides leaf extract on E. coli biofilm formation was then
evaluated using a membrane-supporting biofilm reactor,
which allowed the formation of a biofilm at the solid/air
interface. This technique forced the cells to attach to a sur-
face, a feature that allowed direct investigation of the effect
of the selected extract on the development of the biofilm,
whilst bypassing the effect on the adhesion phase.
No significant reduction in the number of viable cells
during biofilm formation on the membrane treated with
the extract, compared to the untreated, after 18 h in all
the experimental conditions was observed. Treatment 3
showed a growth rate slowdown in the interval 6–8 h, in
which E. coli cells were in contact with the extract dur-
ing both overnight growth and biofilm formation (reduc-
tion of cellular growth, compared to the control, up to
48.64 ± 4.02%). Interestingly, treatment 3 showed a bi-
phasic growth curve compared with the growth curves
of the other treatments, a trend that could be explained
by the bioluminescence produced by V. harvey. As sig-
naling molecules play an important role in biofilm devel-
opment and detachment, the effects of 10 mg/l of E.
acoroides leaf extract were investigated using V. harveyi,
suggesting other possible antibiofilm mechanisms of ac-
tion of compounds in the chosen seagrass extract. The
results revealed that at time 8 h, the samples treated
with the leaf extract showed a significant increase in the
relative luminescence emitted, compared to the control
(25.75 ± 7.49). Villa et al. [64] reported an increase of
autoinducer-2 (AI-2) activity and a reduction in biofilm
formation in E. coli cells treated with zosteric acid, a
phenolic compound occurring in the seagrass Zostera
marina. In fact, it has been hypothesized that the
accumulation of AI-2 above a threshold level leads to
reduced biofilm formation due to the induction of a
hypermotile phenotype that is unable to adhere to the
surface [64]. Huber et al. [65] demonstrated that some
polyphenolic compounds containing a gallic acid residue
commonly produced by some plant species inhibited
intercellular communication in bacteria. Truchado et al.
[66] reported the ability of some phytochemical com-
pounds (cinnamaldehyde, ellagic acid, resveratrol, rutin
and pomegranate extract) to interfere with the quorum
sensing system of Yersinia enterocolitica and Erwinia
cartovora.
It has been well known that the antibiofilm activity of
plant extracts is closely linked with the content of sec-
ondary metabolites, such as phenols and/or flavonoids,
which represent the total amount of phenolic com-
pounds in a plant extract [13]. The phenolic compound
content is also deeply associated with the antioxidant
activity of plant extracts [67]. Therefore, we determined
the total phenolic acid (TPC) and flavonoid (TFC) content
and the antioxidant activity (ORAC) of methanolic ex-
tracts in order to highlight features of the most promising
antibiofilm extract, the E. acaroides leaf extract. Results
show that E. acaroides leaf extract presents the lower TPC
and TFC values compared to other seagrasse extracts.
Although the low content of phenolic compounds, the E.
acaroides leaf extract displays a higher ORAC value com-
pared to the root extract. This indicates the abundance of
other, non-phenolic compounds with antioxidant capacity
in the leaves of E. acoroides. Cattò et al. [39] suggested the
importance of antioxidant compounds in hindering
biofilm formation. The researcher discovered that the
mechanism of action behind the antibiofilm performance
Fig. 9 Relative luminescence emitted by Vibrio harveyi in absence (positive control) and in presence of 10 ppm of E. acoroides leaf extract for 24 h.
The relative luminescence has been calculated by normalizing luminescence by the number of adhered cells. Stars indicate statistically significant
differences (Tukey’s HSD, p≤ 0.05) between the means of three independent replicates. (C + = Positive control; EAL = Enhalus acoroides leaf)
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of zosteric acid, a secondary metabolite of the seagrass
Zostera marina, is related to the antioxidant activity of the
molecule, and its interaction with the WrbA protein re-
sponsible maintaining cellular homeostasis and defense
against oxidative stress.
To gain more insight into possible antibiofilm com-
pounds in the seagrass extracts, individual substances in
the methanolic extract were analyzed by LC-MS. Prelim-
inary analysis shows that the phytochemical profile of
the E. acaroides leaf extract is mainly characterized by
the presence of the flavones apigenin and luteolin, three
kaempferol derivates and the carboxylic acids benzoic
and azelaic acid. This unique quantitative and qualitative
chemical composition confers antibiofilm properties to
the E. acaroides leaf extract.
Some of these compounds have shown to exhibit anti-
biofilm properties at non-lethal concentrations. Kaemp-
ferol, apigenin and luteolin from red wine reduced
biofilm formation of methicillin-sensitive S. aureus sig-
nificantly [68]. Sánchez et colleagues [69] reported that
sub-lethal concentrations of plant extracts inhibit E. coli
and S. aureus biofilms. The antibiofilm properties of the
extracts were associated to the presence of flavonoids,
such as kaempferol and apigenin, which modulate bac-
terial cell-cell communication by suppressing the activity
of the autoinducer-2 [70]. However, we should keep in
mind that the antibiofilm effects of plant extracts could
be the result of interactions among different compo-
nents of the extract at specific concentrations, and not
only due to the effects of a single, predominant com-
pound [4, 71].
Conclusions
In conclusion, the E. acoroides leaf extract proved to be
the most promising extract among those tested. Indeed,
the selected non-lethal concentrations of E. acoroides
leaf extract were found to exert an antibiofilm effect on
C. albicans and E. coli biofilm in the first phase of bio-
film genesis, opening up the possibility of developing
preventive strategies to hinder the adhesion of micro-
bial cells to surfaces. The leaf extract also affected the
dispersion and maturation steps in C. albicans and E.
coli respectively, suggesting an important role in cell
signaling processes. These effects could be explained by
the presence of active compounds like kaempferol and
apigenin at specific concentrations in the extracts of E.
acoroides, which are known to possess biofilm inhibit-
ing properties. Furthermore, there could be a synergis-
tic action of these flavonoids with other compounds
occurring in the plant, enhancing the global antibiofilm
effect. Currently, the leaf extract is being investigated
with the objective of testing fractions for identifying the
active compounds and to better understand the mecha-
nisms of action of this seagrass species.
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